Command Palette

Search for a command to run...

Preprint WatchMildOctober 2nd, 2026

SIK3 links synaptic strength to sleep pressure through RhoA signaling

Kitazono, T.; Juichi, M.; Nishida, K.; Nomura, S.; Shimizu, C.; Kato, A.; Iino, Y.; Higashide, N.; Miyanishi, K.; Nakata, S.; Ageta-Ishihara, N.; Sawada, T.; Shi, S.; Funato, H.; Yanagisawa, M.

SIK3 enlarges dendritic spine size and raises non-REM sleep EEG delta density through two opposing RhoA-dependent pathways. Chemical long-term potentiation reduced RhoA activity in an SIK3-dependent manner, while SIK3 phosphorylation activates the RhoA regulator GEF-H1, and the authors report these as clashing SIK3 to RhoA pathways coupling synaptic regulation to sleep homeostasis.

Mild contradiction

1 prior failure

One documented clinical failure (Phase 1 or 2) overlaps with the claimed mechanism.

The single SIK3 entry in the Claidex graph is an oncology programme, OMX-0407 in advanced solid tumours, which stopped as a sponsor decision rather than on data (omx-0407-sik3-advanced-solid-tumors-phase1-1b-strategic-termination). This preprint is CNS biology and does not speak to that indication, but it carries a liability signal for any systemic SIK3 inhibitor. SIK3 is shown here to be required for activity-dependent spine enlargement in cortical pyramidal neurons and to set non-REM delta density in vivo, so central nervous system exposure of a SIK3 inhibitor would be expected to perturb sleep architecture and synaptic plasticity on target. A programme reviving SIK3 inhibition should measure brain penetration and collect sleep endpoints early rather than treating central effects as an off-target risk.

Abstract excerpt

Sleep is regulated by homeostatic sleep pressure, which accumulates during wakefulness, triggering sleep, and dissipates during sleep, leading to wakefulness. Although recent evidence suggests that synaptic potentiation encodes sleep pressure, the intracellular mechanisms linking synaptic strength to sleep pressure remain unclear. Here we demonstrate that the sleep-promoting kinase SIK3 links synaptic strength and sleep pressure through RhoA signalling. We found that SIK3 is required for dendritic spine enlargement induced by chemical long-term potentiation (cLTP) in cultured cortical pyramidal neurons and positively regulates spine size in the prefrontal cortex in vivo. cLTP reduced RhoA activity in an SIK3-dependent manner during spine enlargement, whereas activation of RhoA reduced EEG delta density in vivo during non-rapid eye movement sleep (NREMS), an indicator of sleep pressure. SIK3 substrate screening identified several RhoA regulators including GEF-H1, and further biochemical analyses found that phosphorylation by SIK3 activates GEF-H1. However, contrary to our expectation, RhoA facilitation through pharmacological activation of GEF-H1 enlarged spine size in cultured neurons, and expression of constitutively active GEF-H1 increased NREMS delta density in a RhoA-dependent fashion. Together, these results indicate that SIK3 enlarges spine size and enhances NREMS delta density through two RhoA-dependent pathways, driving mutually opposing intermediate phenotypes. Our findings identify two clashing SIK3-RhoA signalling pathways that couple synaptic regulation to sleep homeostasis.

Matching Claidex post-mortems

1 of 1 indexed

This is an automated contradiction flag, not an editorial judgment on the preprint's quality. Flags identify where the preclinical literature and the clinical failure record diverge.